BiotechTube
Home/KeyZell/Dr. Nabil Hajji
DN

Dr. Nabil Hajji

Investigator

KeyZell

Therapeutic Areas

Oncology

KeyZell Pipeline

DrugIndicationPhase
LZ-167Oncology (specific indications not disclosed)Pre-clinical

Leadership Team at KeyZell

MV
Miguel Vilaplana
Chairman
JD
José del Corral
Chief Executive Officer (CEO)
View full KeyZell profile